Lv2
180 积分 2020-10-28 加入
GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial
28天前
已完结
Mouse models of high-risk neuroblastoma
4个月前
已关闭
Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis
5个月前
已完结
An update on regulation and function of G protein-coupled receptors in cancer: A promising strategy for cancer therapy
6个月前
已完结
Building Endogenous Gene Connections through RNA Self-Assembly Controlled CRISPR/Cas9 Function
6个月前
已完结
Targeting Osteoblast‐Osteoclast Cross‐Talk Bone Homeostasis Repair Microcarriers Promotes Intervertebral Fusion in Osteoporotic Rats
7个月前
已完结
Leveraging T cell-specific fusogenicity of HIV for in vivo mRNA delivery to produce human CAR-T cells
7个月前
已完结
Synergistic Integration of mRNA-LNP with CAR-Engineered Immune Cells: Pioneering Progress in Immunotherapy
8个月前
已完结
Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo
8个月前
已完结
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
8个月前
已完结
皖公网安备34019202002308
